Factor X

Topical RNA Delivery Platform for Precision Skin Longevity and Cosmetic Performance

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in December 2025 by Inbal Gat and Shira Orr, Factor X operates with 1-10 employees. The company closed a Pre-Seed funding round in July 2026.

Business overview

Factor X is developing a cosmetic-grade topical delivery platform designed to deliver RNA and other active payloads across the skin barrier to specific skin layers. This platform targets skincare and cosmetic partners seeking precise, stable, and efficient formulations for applications such as skin longevity, UV-damaged skin, hair color, and hair regrowth. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Cosmetic Materials, serving enterprise and professional services, including SMBs and larger enterprises.

Strategic signal

In July 2026, Factor X closed a Pre-Seed funding round, signaling early investor confidence in its innovative topical RNA delivery platform. This capital infusion is crucial for advancing the company's R&D efforts in precision skin longevity and cosmetic performance, positioning Factor X to potentially disrupt the skincare and cosmetic industries with more effective and targeted formulations.

Company Intelligence Q&A

When was Factor X founded?
Factor X was founded in December 2025.
Who are the co-founders of Factor X?
Factor X was co-founded by Inbal Gat and Shira Orr.
What is Factor X's core technology?
Factor X is developing a cosmetic-grade topical delivery platform that carries RNA and other active payloads across the skin barrier to specific skin layers.
Which industries does Factor X's platform target?
Factor X's platform is intended for skincare and cosmetic partners seeking formulations for skin longevity, UV-damaged skin, hair color, and hair regrowth applications.